• Je něco špatně v tomto záznamu ?

Guanylhydrazone and semicarbazone derivatives as potential prototypes for the design of cholinesterase inhibitors against Alzheimer's disease: biological evaluation and molecular modeling studies

DCF. Neto, JSF. Diz, SJA. Guimarães, EM. Dos Santos, MDDSB. Nascimento, APS. de Azevedo-Santos, TCC. França, SR. LaPlante, CJ. do Nascimento, JA. Lima

. 2025 ; 415 (-) : 111515. [pub] 20250415

Jazyk angličtina Země Irsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25015200

Despite being present in many drugs, guanylhydrazones and semicarbazones are two functional groups that have been little investigated as potential therapeutic strategies for the treatment of Alzheimer's disease (AD). For this reason, we initiated the synthesis and evaluation of these compounds as potential anticholinesterase agents, aiming to offer new alternatives for drug development against AD. In the severe phase of AD butyrylcholinesterase (BChE) becomes the main enzyme responsible for the hydrolysis of acetylcholine (ACh). Therefore, in this project, we present the results of BChE inhibitory activity, enzyme kinetics, cytotoxicity, and molecular modeling studies for three guanylhydrazone and two semicarbazone derivatives that were previously synthesized and evaluated as acetylcholinesterase (AChE) inhibitors. Among the compounds tested, guanylhydrazones (1, 2, and 3) showed inhibitory activity against BChE, exhibiting a mixed non-competitive inhibition profile. Specifically, compound 2 (phenanthrenequinone) demonstrated superior inhibitory potency with an IC50 of 0.68 μM, compared to compound 1 (acridinone) with an IC50 of 3.87 μM, and compound 3 (benzodioxole) with an IC50 of 101.7 μM. In contrast, semicarbazones (4 and 5) showed no BChE inhibition up to the highest concentration tested (300 μM). Importantly, all five compounds were found to be non-cytotoxic. Our results suggest that these compounds have potential as drug prototypes targeting different phases of AD. Compounds 3, 4, and 5 may be more effective in the early phase, when AChE activity remains high; compound 1 could be useful in the intermediate phase; and compound 2 appears particularly promising for the severe phase, when BChE plays a more dominant role.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25015200
003      
CZ-PrNML
005      
20250731090828.0
007      
ta
008      
250708e20250415ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.cbi.2025.111515 $2 doi
035    __
$a (PubMed)40246050
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Neto, Denise Cristian Ferreira $u Medicinal Chemistry Group, Department of Chemistry, Military Institute of Engineering, Praça General Tibúrcio 80, 22290-270, Rio de Janeiro, RJ, Brazil; Department of Chemistry, Federal University of Roraima, Av. Cap. Ene Garcês, 2413, 69310-000, Boa Vista, Roraima, Brazil. Electronic address: denisecristian@ime.eb.br
245    10
$a Guanylhydrazone and semicarbazone derivatives as potential prototypes for the design of cholinesterase inhibitors against Alzheimer's disease: biological evaluation and molecular modeling studies / $c DCF. Neto, JSF. Diz, SJA. Guimarães, EM. Dos Santos, MDDSB. Nascimento, APS. de Azevedo-Santos, TCC. França, SR. LaPlante, CJ. do Nascimento, JA. Lima
520    9_
$a Despite being present in many drugs, guanylhydrazones and semicarbazones are two functional groups that have been little investigated as potential therapeutic strategies for the treatment of Alzheimer's disease (AD). For this reason, we initiated the synthesis and evaluation of these compounds as potential anticholinesterase agents, aiming to offer new alternatives for drug development against AD. In the severe phase of AD butyrylcholinesterase (BChE) becomes the main enzyme responsible for the hydrolysis of acetylcholine (ACh). Therefore, in this project, we present the results of BChE inhibitory activity, enzyme kinetics, cytotoxicity, and molecular modeling studies for three guanylhydrazone and two semicarbazone derivatives that were previously synthesized and evaluated as acetylcholinesterase (AChE) inhibitors. Among the compounds tested, guanylhydrazones (1, 2, and 3) showed inhibitory activity against BChE, exhibiting a mixed non-competitive inhibition profile. Specifically, compound 2 (phenanthrenequinone) demonstrated superior inhibitory potency with an IC50 of 0.68 μM, compared to compound 1 (acridinone) with an IC50 of 3.87 μM, and compound 3 (benzodioxole) with an IC50 of 101.7 μM. In contrast, semicarbazones (4 and 5) showed no BChE inhibition up to the highest concentration tested (300 μM). Importantly, all five compounds were found to be non-cytotoxic. Our results suggest that these compounds have potential as drug prototypes targeting different phases of AD. Compounds 3, 4, and 5 may be more effective in the early phase, when AChE activity remains high; compound 1 could be useful in the intermediate phase; and compound 2 appears particularly promising for the severe phase, when BChE plays a more dominant role.
650    12
$a cholinesterasové inhibitory $x chemie $x farmakologie $x metabolismus $x terapeutické užití $x chemická syntéza $7 D002800
650    12
$a Alzheimerova nemoc $x farmakoterapie $7 D000544
650    12
$a semikarbazony $x chemie $x farmakologie $x metabolismus $7 D012664
650    12
$a hydrazony $x chemie $x farmakologie $7 D006835
650    _2
$a butyrylcholinesterasa $x metabolismus $x chemie $7 D002091
650    _2
$a lidé $7 D006801
650    _2
$a acetylcholinesterasa $x metabolismus $x chemie $7 D000110
650    _2
$a simulace molekulového dockingu $7 D062105
650    12
$a racionální návrh léčiv $7 D015195
650    _2
$a kinetika $7 D007700
650    _2
$a zvířata $7 D000818
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a molekulární modely $7 D008958
655    _2
$a časopisecké články $7 D016428
700    1_
$a Diz, Joyce Sobreiro Francisco $u Laboratory of Molecular Modeling Applied to the Chemical and Biological Defense (LMCBD), Military Institute of Engineering (IME), Praça General Tibúrcio 80, 22290-270, Rio de Janeiro, Brazil; Institute of Chemical, Biological, Radiological and Nuclear Defense (IDQBRN), Brazilian Army Technological Center (CTEx), Av. das Américas 28705, Área 4, 23020-470, Rio de Janeiro, RJ, Brazil
700    1_
$a Guimarães, Sulayne Janayna Araújo $u Laboratory for Applied Cancer Immunology, Biological and Health Sciences Center, Federal University of Maranhão, Avenida dos Portugueses, 1966, Bacanga, 65080-805, São Luís, Maranhão, Brazil
700    1_
$a Dos Santos, Eduardo Mendes $u Federal University of Maranhão, Postgraduate Program in Adult Health (PPGSAD), Avenida dos Portugueses, 1966, Bacanga, 65080-805, São Luís, Maranhão, Brazil
700    1_
$a Nascimento, Maria do Desterro Soares Brandão $u Federal University of Maranhão, Postgraduate Program in Adult Health (PPGSAD), Avenida dos Portugueses, 1966, Bacanga, 65080-805, São Luís, Maranhão, Brazil
700    1_
$a de Azevedo-Santos, Ana Paula Silva $u Laboratory for Applied Cancer Immunology, Biological and Health Sciences Center, Federal University of Maranhão, Avenida dos Portugueses, 1966, Bacanga, 65080-805, São Luís, Maranhão, Brazil
700    1_
$a França, Tanos Celmar Costa $u Laboratory of Molecular Modeling Applied to the Chemical and Biological Defense (LMCBD), Military Institute of Engineering (IME), Praça General Tibúrcio 80, 22290-270, Rio de Janeiro, Brazil; Université de Québec, INRS - Centre Armand-Frappier Santé Biotechnologie, 531 boulevard des Prairies, Laval, Québec, H7V 1B7, Canada; Center for Basic and Applied Research, Faculty of Informatics and Management, University of Hradec Kralove, 50003, Hradec Kralove, Czech Republic
700    1_
$a LaPlante, Steven R $u Université de Québec, INRS - Centre Armand-Frappier Santé Biotechnologie, 531 boulevard des Prairies, Laval, Québec, H7V 1B7, Canada
700    1_
$a do Nascimento, Claudia Jorge $u Institute of Biosciences, Federal University of the State of Rio de Janeiro, Av. Pasteur, 296, Urca, 22290-250, Rio de Janeiro, Brazil
700    1_
$a Lima, Josélia Alencar $u Federal University of Maranhão, Postgraduate Program in Adult Health (PPGSAD), Avenida dos Portugueses, 1966, Bacanga, 65080-805, São Luís, Maranhão, Brazil. Electronic address: joselialima@terra.com.br
773    0_
$w MED00002111 $t Chemico-biological interactions $x 1872-7786 $g Roč. 415 (20250415), s. 111515
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40246050 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731090822 $b ABA008
999    __
$a ok $b bmc $g 2366198 $s 1252325
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 415 $c - $d 111515 $e 20250415 $i 1872-7786 $m Chemico-biological interactions $n Chem Biol Interact $x MED00002111
LZP    __
$a Pubmed-20250708

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...